Success Story
Breaking Through Market Access Barriers
How does a novel rheumatoid arthritis therapy overcome entrenched competition to develop broad payer coverage?

Bringing a novel therapy to market is no small feat, especially in a landscape dominated by well-established treatments.
For one biopharmaceutical company, securing adoption was a strategic knot: payers were hesitant to offer broad coverage, and healthcare providers remained cautious without strong formulary placement. Without a breakthrough market access approach, the therapy risked being overlooked in a competitive market.
In this case study, learn how TJP untied the knot by engaging key stakeholders, building a compelling case with payers, and ultimately positioning the therapy for widespread adoption
Read the success story to learn:
- How a data-driven value story reshaped payer perceptions to achieve 99% commercial insurance coverage, broad support from all major payers, and rapid prescriber uptake
- The role of HEOR-backed engagement in securing formulary placement
- The impact of persona-based digital tools in tailoring outreach to distinct stakeholders, building prescriber awareness, and facilitating peer-to-peer education.
